Healwell AI is a health care technology company focused on artificial intelligence and data science for preventative care, early identification and detection of disease. Clarus acted as co-manager on the underwritten offering to fund the Company's acquisition of Orion Health Holdings Ltd. and for general corporate and working capital purposes.

QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. Clarus led a $3.4MM public offering to help fund the build out of the Company's Indian operations.

Operating through 183 Company-operated treatment centers, Greenbrook TMS is a leading provider of Transcranial Magnetic Stimulation therapy and esketamine nasal spray. FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder and other mental health disorders in the United States. Clarus was retained to perform a fairness opinion to Greenbrook in connection with the company's proposed acquisition of Check Five LLC.

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics across North America. Clarus provided a fairness opinion to Novamind in connection with the company's proposed sale to Numinus Wellness.

QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. Clarus led the $11.5 million bought deal financing to support the Company's growth initiatives and the continued build-out of its Indian operations.

MCI Onehealth is operates 25 technology enabled clinics and serves over 850,000 patients through advanced technologies to increase access, improve quality, and reduce the cost of healthcare. Clarus is involved with the $30 million IPO financing for its growth initiatives.

StageZero Life Sciences Ltd. is a biotechnology company dedicated on development and commercialization of its next generation test, Aristotle®, a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood. Clarus co-led the $7.2 million public offering to support the Company's growth and development initiatives.

StageZero Life Sciences Ltd. is a biotechnology company dedicated on development and commercialization of its next generation test, Aristotle®, a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood. Clarus co-led the $4.6 million public offering to support the Company's growth and development initiatives.

HLS Therapeutics is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. Clarus was a co-manager of a C$50 million common share offering used to support the launch of HLS's growing pipeline of products and for working capital and general corporate purposes.

Greenbrook is a leading provider of TMS, an FDA cleared, non-invasive therapy for the treatment of Major Depressive Disorder. The offering will be used to fund the opening of new Greenbrook TMS centers and future acquisitions.

QYOU Media Inc. is a fast-growing global media company that curates and packages premium content from leading digital video creators for multiscreen distribution. The financing used to fund QYOU's expansion into India and content development.

OneSoft has developed software technology products that have the capability to transition legacy software applications to operate on the Microsoft Azure Cloud Platform. The funding will be used to accelerate new product development, marketing, and growth initiatives, some of which relate to its predictive pipeline failure services.

The proceeds of the offering will be used to continue expanding the business as QYOU looks to build a top-tier global media company.

CryptoGlobal Inc. retained Clarus Securities to perform a fairness opinion during HyperBlock Technologies Corp.'s proposed takeover of the company. This acquisition creates a leader in creating, managing and safeguarding crypto assets.

Globalive Technology Partners is an investment company focusing on disrupting traditional industries through investments in machine learning and blockchain technology. Clarus co-led the private placement.

Urthecast Corp. is a technology company that focuses on developing industry leading earth-imaging systems. Clarus co-led a financing under difficult circumstances to support the company as it continues to build out it's world class technologies.

Leonovus Inc. is a cloud solutions software provider that utilizes blockchain technology within the company's data storage product offerings.

QYOU is a media company that curates and packages premium web content for multiscreen distribution. This financing will provide the company with capital to further expand the business.

UrtheCast Corp. is a technology company that operates four Earth observation sensors in space, including two cameras aboard the International Space Station and two satellites, Deimos-1 and Deimos-2. The Company is also developing and anticipates launching a fully-integrated constellation of multispectral optical and SAR satellites. Clarus led a $20.0 million financing that provides general working capital for the Company as it continues to pursue the development of its OptiSAR constellation.

Clarus led $4.9 million financing to help fund the growth of Breaking Data Corp.—a technology provider of semantic search, machine learning and natural language processing ("NLP").

Savaria Corporation is one of North America's leaders in the accessibility industry. It provides accessibility solutions for the elderly and physically-challenged to increase their mobility and independence. The diversity of its product line is one of the most comprehensive on the market.

Firan is an aerospace and defense electronic product and subsystem supplier to customers around the globe. Clarus co-managed a $6.9 million financing to help fund growth and acquisition opportunities.

Merus is a rapidly growing Canadian specialty pharmaceutical company that acquires legacy pharmaceutical products for distribution mainly in Europe, but also in Canada. Clarus has co-led five equity transactions totaling over $155 million which has helped fund recent and future acquisitions.

GoldMoney (formerly BitGold) is a transformational Canadian international savings and payments service firm that allows people and businesses to send payments and transfers with physical gold. Clarus has played a significant role in raising the company $60 million through three oversubscribed financings.

Involved with UrtheCast when it was private UrtheCast has delivered on its goal of becoming an innovator in the earth observation market having installed cameras on the International Space Station. Clarus has helped raise UrtheCast over $150 million in equity through 4 transactions over the last 2 years, adding over 40 long-term institutional shareholders.

After achieving tremendous success as a one-product company, CRH identified a major opportunity in the Gastro-Intestinal anesthesia market in the U.S. Clarus subsequently raised over $27 million in a very successful public offering that restored its financial capacity.